Ghersin, I.; Fischman, M.; Calini, G.; Koifman, E.; Celentano, V.; Segal, J.P.; Argyriou, O.; McLaughlin, S.D.; Johnson, H.; Rottoli, M.;
et al. Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study. Biomedicines 2025, 13, 1870.
https://doi.org/10.3390/biomedicines13081870
AMA Style
Ghersin I, Fischman M, Calini G, Koifman E, Celentano V, Segal JP, Argyriou O, McLaughlin SD, Johnson H, Rottoli M,
et al. Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study. Biomedicines. 2025; 13(8):1870.
https://doi.org/10.3390/biomedicines13081870
Chicago/Turabian Style
Ghersin, Itai, Maya Fischman, Giacomo Calini, Eduard Koifman, Valerio Celentano, Jonathan P. Segal, Orestis Argyriou, Simon D. McLaughlin, Heather Johnson, Matteo Rottoli,
and et al. 2025. "Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study" Biomedicines 13, no. 8: 1870.
https://doi.org/10.3390/biomedicines13081870
APA Style
Ghersin, I., Fischman, M., Calini, G., Koifman, E., Celentano, V., Segal, J. P., Argyriou, O., McLaughlin, S. D., Johnson, H., Rottoli, M., Sahnan, K., Warusavitarne, J., & Hart, A. L.
(2025). Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study. Biomedicines, 13(8), 1870.
https://doi.org/10.3390/biomedicines13081870
